nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—systemic scleroderma—Colchicine—primary biliary cirrhosis	0.433	1	CpDpCtD
Tadalafil—PDE5A—primary biliary cirrhosis	0.418	1	CbGaD
Tadalafil—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.037	0.664	CbGbCtD
Tadalafil—CYP3A4—Colchicine—primary biliary cirrhosis	0.0187	0.336	CbGbCtD
Tadalafil—PDE11A—cGMP effects—PDE5A—primary biliary cirrhosis	0.00482	0.235	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—PDE5A—primary biliary cirrhosis	0.00383	0.186	CbGpPWpGaD
Tadalafil—Pulmonary hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.0257	CcSEcCtD
Tadalafil—Pulmonary hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.0257	CcSEcCtD
Tadalafil—PDE11A—epithelium—primary biliary cirrhosis	0.00177	0.42	CbGeAlD
Tadalafil—PDE11A—Platelet homeostasis—PDE5A—primary biliary cirrhosis	0.00149	0.0726	CbGpPWpGaD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00114	0.0555	CbGpPWpGaD
Tadalafil—PDE11A—liver—primary biliary cirrhosis	0.001	0.238	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—primary biliary cirrhosis	0.000934	0.0455	CbGpPWpGaD
Tadalafil—Menorrhagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00089	0.0129	CcSEcCtD
Tadalafil—Menorrhagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00089	0.0129	CcSEcCtD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.000864	0.0421	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—primary biliary cirrhosis	0.000833	0.0406	CbGpPWpGaD
Tadalafil—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00075	0.0109	CcSEcCtD
Tadalafil—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00075	0.0109	CcSEcCtD
Tadalafil—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000729	0.0106	CcSEcCtD
Tadalafil—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000729	0.0106	CcSEcCtD
Tadalafil—PDE5A—epithelium—primary biliary cirrhosis	0.000673	0.16	CbGeAlD
Tadalafil—Neck pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000667	0.00968	CcSEcCtD
Tadalafil—Neck pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000667	0.00968	CcSEcCtD
Tadalafil—PDE5A—smooth muscle tissue—primary biliary cirrhosis	0.000648	0.154	CbGeAlD
Tadalafil—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000602	0.00874	CcSEcCtD
Tadalafil—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000602	0.00874	CcSEcCtD
Tadalafil—Deafness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00776	CcSEcCtD
Tadalafil—Deafness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00776	CcSEcCtD
Tadalafil—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000509	0.00739	CcSEcCtD
Tadalafil—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000509	0.00739	CcSEcCtD
Tadalafil—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000502	0.0073	CcSEcCtD
Tadalafil—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000502	0.0073	CcSEcCtD
Tadalafil—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00709	CcSEcCtD
Tadalafil—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00709	CcSEcCtD
Tadalafil—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000476	0.0232	CbGpPWpGaD
Tadalafil—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00684	CcSEcCtD
Tadalafil—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00684	CcSEcCtD
Tadalafil—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000462	0.0067	CcSEcCtD
Tadalafil—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000462	0.0067	CcSEcCtD
Tadalafil—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00641	CcSEcCtD
Tadalafil—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00641	CcSEcCtD
Tadalafil—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000441	0.0064	CcSEcCtD
Tadalafil—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00634	CcSEcCtD
Tadalafil—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00634	CcSEcCtD
Tadalafil—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00634	CcSEcCtD
Tadalafil—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00634	CcSEcCtD
Tadalafil—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00628	CcSEcCtD
Tadalafil—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00628	CcSEcCtD
Tadalafil—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000423	0.00615	CcSEcCtD
Tadalafil—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000423	0.00615	CcSEcCtD
Tadalafil—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.006	CcSEcCtD
Tadalafil—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.006	CcSEcCtD
Tadalafil—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.006	CcSEcCtD
Tadalafil—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.006	CcSEcCtD
Tadalafil—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000403	0.00585	CcSEcCtD
Tadalafil—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000403	0.00585	CcSEcCtD
Tadalafil—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00577	CcSEcCtD
Tadalafil—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00577	CcSEcCtD
Tadalafil—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00575	CcSEcCtD
Tadalafil—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00575	CcSEcCtD
Tadalafil—Haematuria—Colchicine—primary biliary cirrhosis	0.000391	0.00568	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00558	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00558	CcSEcCtD
Tadalafil—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00535	CcSEcCtD
Tadalafil—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00535	CcSEcCtD
Tadalafil—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00535	CcSEcCtD
Tadalafil—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000369	0.00535	CcSEcCtD
Tadalafil—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000366	0.00532	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—primary biliary cirrhosis	0.000364	0.0177	CbGpPWpGaD
Tadalafil—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000363	0.00528	CcSEcCtD
Tadalafil—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000363	0.00528	CcSEcCtD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000363	0.0177	CbGpPWpGaD
Tadalafil—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00526	CcSEcCtD
Tadalafil—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00526	CcSEcCtD
Tadalafil—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00525	CcSEcCtD
Tadalafil—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00525	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—RAD51B—primary biliary cirrhosis	0.000359	0.0175	CbGpPWpGaD
Tadalafil—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.0052	CcSEcCtD
Tadalafil—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.0052	CcSEcCtD
Tadalafil—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.0052	CcSEcCtD
Tadalafil—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.0052	CcSEcCtD
Tadalafil—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00513	CcSEcCtD
Tadalafil—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00513	CcSEcCtD
Tadalafil—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000351	0.0051	CcSEcCtD
Tadalafil—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000351	0.0051	CcSEcCtD
Tadalafil—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00505	CcSEcCtD
Tadalafil—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00505	CcSEcCtD
Tadalafil—Eye disorder—Colchicine—primary biliary cirrhosis	0.000344	0.005	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PDE5A—primary biliary cirrhosis	0.000334	0.0163	CbGpPWpGaD
Tadalafil—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00483	CcSEcCtD
Tadalafil—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00483	CcSEcCtD
Tadalafil—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000332	0.00482	CcSEcCtD
Tadalafil—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00482	CcSEcCtD
Tadalafil—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00482	CcSEcCtD
Tadalafil—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000331	0.0048	CcSEcCtD
Tadalafil—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000331	0.0048	CcSEcCtD
Tadalafil—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00477	CcSEcCtD
Tadalafil—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00477	CcSEcCtD
Tadalafil—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00474	CcSEcCtD
Tadalafil—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00474	CcSEcCtD
Tadalafil—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00473	CcSEcCtD
Tadalafil—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00473	CcSEcCtD
Tadalafil—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00472	CcSEcCtD
Tadalafil—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00472	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—primary biliary cirrhosis	0.000324	0.0158	CbGpPWpGaD
Tadalafil—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00471	CcSEcCtD
Tadalafil—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00471	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—RAD51B—primary biliary cirrhosis	0.00032	0.0156	CbGpPWpGaD
Tadalafil—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00449	CcSEcCtD
Tadalafil—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00449	CcSEcCtD
Tadalafil—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000308	0.00448	CcSEcCtD
Tadalafil—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000308	0.00448	CcSEcCtD
Tadalafil—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000308	0.00448	CcSEcCtD
Tadalafil—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00446	CcSEcCtD
Tadalafil—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00446	CcSEcCtD
Tadalafil—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000304	0.0148	CbGpPWpGaD
Tadalafil—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00436	CcSEcCtD
Tadalafil—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00436	CcSEcCtD
Tadalafil—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00434	CcSEcCtD
Tadalafil—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00434	CcSEcCtD
Tadalafil—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00433	CcSEcCtD
Tadalafil—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00433	CcSEcCtD
Tadalafil—Angioedema—Colchicine—primary biliary cirrhosis	0.000293	0.00425	CcSEcCtD
Tadalafil—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00405	CcSEcCtD
Tadalafil—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00405	CcSEcCtD
Tadalafil—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00402	CcSEcCtD
Tadalafil—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00402	CcSEcCtD
Tadalafil—Arthralgia—Colchicine—primary biliary cirrhosis	0.000273	0.00396	CcSEcCtD
Tadalafil—Myalgia—Colchicine—primary biliary cirrhosis	0.000273	0.00396	CcSEcCtD
Tadalafil—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00382	CcSEcCtD
Tadalafil—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00382	CcSEcCtD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000261	0.0127	CbGpPWpGaD
Tadalafil—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000259	0.0126	CbGpPWpGaD
Tadalafil—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00376	CcSEcCtD
Tadalafil—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00376	CcSEcCtD
Tadalafil—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00375	CcSEcCtD
Tadalafil—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00375	CcSEcCtD
Tadalafil—Shock—Colchicine—primary biliary cirrhosis	0.000257	0.00374	CcSEcCtD
Tadalafil—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000257	0.00373	CcSEcCtD
Tadalafil—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000254	0.0037	CcSEcCtD
Tadalafil—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000254	0.0037	CcSEcCtD
Tadalafil—Skin disorder—Colchicine—primary biliary cirrhosis	0.000254	0.00369	CcSEcCtD
Tadalafil—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000253	0.00368	CcSEcCtD
Tadalafil—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000253	0.00368	CcSEcCtD
Tadalafil—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00365	CcSEcCtD
Tadalafil—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00365	CcSEcCtD
Tadalafil—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00025	0.00362	CcSEcCtD
Tadalafil—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00025	0.00362	CcSEcCtD
Tadalafil—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000249	0.00361	CcSEcCtD
Tadalafil—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000249	0.00361	CcSEcCtD
Tadalafil—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00356	CcSEcCtD
Tadalafil—Hypotension—Colchicine—primary biliary cirrhosis	0.000244	0.00355	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000243	0.00354	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000243	0.00354	CcSEcCtD
Tadalafil—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00352	CcSEcCtD
Tadalafil—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00352	CcSEcCtD
Tadalafil—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00348	CcSEcCtD
Tadalafil—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00348	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000238	0.00346	CcSEcCtD
Tadalafil—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00341	CcSEcCtD
Tadalafil—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00341	CcSEcCtD
Tadalafil—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00339	CcSEcCtD
Tadalafil—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00339	CcSEcCtD
Tadalafil—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00336	CcSEcCtD
Tadalafil—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00336	CcSEcCtD
Tadalafil—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00335	CcSEcCtD
Tadalafil—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00335	CcSEcCtD
Tadalafil—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00333	CcSEcCtD
Tadalafil—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00333	CcSEcCtD
Tadalafil—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00332	CcSEcCtD
Tadalafil—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00332	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000228	0.0111	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000227	0.0033	CcSEcCtD
Tadalafil—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000227	0.0033	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000226	0.00328	CcSEcCtD
Tadalafil—Fatigue—Colchicine—primary biliary cirrhosis	0.000226	0.00328	CcSEcCtD
Tadalafil—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00319	CcSEcCtD
Tadalafil—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00319	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00311	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00311	CcSEcCtD
Tadalafil—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000214	0.00311	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000213	0.0104	CbGpPWpGaD
Tadalafil—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00309	CcSEcCtD
Tadalafil—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00309	CcSEcCtD
Tadalafil—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00307	CcSEcCtD
Tadalafil—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000211	0.00307	CcSEcCtD
Tadalafil—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00304	CcSEcCtD
Tadalafil—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00304	CcSEcCtD
Tadalafil—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00303	CcSEcCtD
Tadalafil—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00303	CcSEcCtD
Tadalafil—Urticaria—Colchicine—primary biliary cirrhosis	0.000208	0.00302	CcSEcCtD
Tadalafil—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.003	CcSEcCtD
Tadalafil—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.003	CcSEcCtD
Tadalafil—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000207	0.003	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00295	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00295	CcSEcCtD
Tadalafil—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00294	CcSEcCtD
Tadalafil—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00294	CcSEcCtD
Tadalafil—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00292	CcSEcCtD
Tadalafil—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00292	CcSEcCtD
Tadalafil—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00292	CcSEcCtD
Tadalafil—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00292	CcSEcCtD
Tadalafil—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000193	0.0028	CcSEcCtD
Tadalafil—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00279	CcSEcCtD
Tadalafil—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00279	CcSEcCtD
Tadalafil—Asthenia—Colchicine—primary biliary cirrhosis	0.000188	0.00273	CcSEcCtD
Tadalafil—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000187	0.00271	CcSEcCtD
Tadalafil—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000187	0.00271	CcSEcCtD
Tadalafil—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000186	0.0027	CcSEcCtD
Tadalafil—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000186	0.0027	CcSEcCtD
Tadalafil—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000179	0.0026	CcSEcCtD
Tadalafil—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00251	CcSEcCtD
Tadalafil—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00251	CcSEcCtD
Tadalafil—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00245	CcSEcCtD
Tadalafil—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00245	CcSEcCtD
Tadalafil—Vomiting—Colchicine—primary biliary cirrhosis	0.000166	0.00242	CcSEcCtD
Tadalafil—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00242	CcSEcCtD
Tadalafil—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00242	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000166	0.00807	CbGpPWpGaD
Tadalafil—Rash—Colchicine—primary biliary cirrhosis	0.000165	0.0024	CcSEcCtD
Tadalafil—Dermatitis—Colchicine—primary biliary cirrhosis	0.000165	0.00239	CcSEcCtD
Tadalafil—Headache—Colchicine—primary biliary cirrhosis	0.000164	0.00238	CcSEcCtD
Tadalafil—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000161	0.00234	CcSEcCtD
Tadalafil—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000161	0.00234	CcSEcCtD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000157	0.00765	CbGpPWpGaD
Tadalafil—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00226	CcSEcCtD
Tadalafil—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00226	CcSEcCtD
Tadalafil—Nausea—Colchicine—primary biliary cirrhosis	0.000155	0.00226	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00015	0.00733	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00015	0.00733	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00015	0.00729	CbGpPWpGaD
Tadalafil—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00217	CcSEcCtD
Tadalafil—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00217	CcSEcCtD
Tadalafil—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000149	0.00725	CbGpPWpGaD
Tadalafil—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00215	CcSEcCtD
Tadalafil—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00215	CcSEcCtD
Tadalafil—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00215	CcSEcCtD
Tadalafil—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00215	CcSEcCtD
Tadalafil—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000147	0.00214	CcSEcCtD
Tadalafil—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000147	0.00214	CcSEcCtD
Tadalafil—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00014	0.00203	CcSEcCtD
Tadalafil—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00014	0.00203	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000137	0.00666	CbGpPWpGaD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000132	0.00645	CbGpPWpGaD
Tadalafil—CYP3A4—liver—primary biliary cirrhosis	0.000119	0.0282	CbGeAlD
Tadalafil—PDE11A—Signaling Pathways—CDH5—primary biliary cirrhosis	9.24e-05	0.0045	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR5—primary biliary cirrhosis	8.89e-05	0.00433	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	8.73e-05	0.00425	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—primary biliary cirrhosis	8.15e-05	0.00397	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL9—primary biliary cirrhosis	8.07e-05	0.00393	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	7.84e-05	0.00382	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ELMO1—primary biliary cirrhosis	7.47e-05	0.00364	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—primary biliary cirrhosis	7.27e-05	0.00354	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	7.12e-05	0.00347	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—primary biliary cirrhosis	6.85e-05	0.00334	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	6.75e-05	0.00329	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MMP3—primary biliary cirrhosis	6.49e-05	0.00316	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL5—primary biliary cirrhosis	6.13e-05	0.00298	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—primary biliary cirrhosis	6.11e-05	0.00297	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—primary biliary cirrhosis	5.64e-05	0.00275	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGT—primary biliary cirrhosis	5.13e-05	0.0025	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.2e-05	0.00205	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP3—primary biliary cirrhosis	3.83e-05	0.00187	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.83e-05	0.00187	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL5—primary biliary cirrhosis	3.62e-05	0.00176	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.51e-05	0.00171	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.04e-05	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—primary biliary cirrhosis	3.03e-05	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD80—primary biliary cirrhosis	2.68e-05	0.00131	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	2.55e-05	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TYK2—primary biliary cirrhosis	2.26e-05	0.0011	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—primary biliary cirrhosis	1.78e-05	0.000868	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.76e-05	0.000859	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.76e-05	0.000856	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.27e-05	0.000619	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.13e-05	0.000552	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.07e-05	0.000519	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.07e-05	0.000519	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	6.4e-06	0.000312	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	5.95e-06	0.00029	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	5.11e-06	0.000249	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	5.06e-06	0.000246	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	4.37e-06	0.000213	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	4.37e-06	0.000213	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.89e-06	0.000189	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.03e-06	0.000147	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.32e-06	0.000113	CbGpPWpGaD
